Michael King
Stock Analyst at EF Hutton
(1.17)
# 2,897
Out of 4,667 analysts
126
Total ratings
37.17%
Success rate
-11.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $11 → $6.5 | $0.12 | +5,236.62% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $1,179 | $2.92 | +40,283.56% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $2.94 | +274.15% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $6.28 | +409.55% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $20.98 | +226.50% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics Holdings | Assumes: Buy | $10 | $0.19 | +5,062.62% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $1.64 | +406.10% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $743.35 | +15.96% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $34.65 | -30.74% | 10 | Apr 28, 2023 | |
| OCEA Ocean Biomedical | Maintains: Buy | $10 → $17 | $0.69 | +2,363.77% | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $166 | $2.67 | +6,117.23% | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $23.72 | +77.07% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $304 | $248.79 | +22.19% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $116 | $13.12 | +784.15% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.37 | +651.82% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $28 | $0.28 | +10,059.65% | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $27.86 | -13.85% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $1.40 | +57,042.86% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $46 | $20.31 | +126.49% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $96 | $54.62 | +75.76% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.94 | +3,724.90% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.58 | +1,965.05% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $9.08 | +241.41% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $180 → $160 | $0.29 | +55,072.41% | 4 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $33 → $36 | $591.82 | -93.92% | 2 | Nov 13, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $11 → $6.5
Current: $0.12
Upside: +5,236.62%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $2.92
Upside: +40,283.56%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $2.94
Upside: +274.15%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $6.28
Upside: +409.55%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $20.98
Upside: +226.50%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $10
Current: $0.19
Upside: +5,062.62%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $1.64
Upside: +406.10%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $743.35
Upside: +15.96%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $34.65
Upside: -30.74%
Ocean Biomedical
Apr 27, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $0.69
Upside: +2,363.77%
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $2.67
Upside: +6,117.23%
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $23.72
Upside: +77.07%
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $248.79
Upside: +22.19%
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $13.12
Upside: +784.15%
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $1.37
Upside: +651.82%
Mar 30, 2022
Maintains: Buy
Price Target: $25 → $28
Current: $0.28
Upside: +10,059.65%
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $27.86
Upside: -13.85%
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $1.40
Upside: +57,042.86%
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $20.31
Upside: +126.49%
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $54.62
Upside: +75.76%
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $0.94
Upside: +3,724.90%
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $0.58
Upside: +1,965.05%
Nov 5, 2021
Maintains: Buy
Price Target: $25 → $31
Current: $9.08
Upside: +241.41%
Oct 18, 2019
Maintains: Market Outperform
Price Target: $180 → $160
Current: $0.29
Upside: +55,072.41%
Nov 13, 2017
Maintains: Market Outperform
Price Target: $33 → $36
Current: $591.82
Upside: -93.92%